Related Experiment Video
Updated: Dec 11, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Impact of calculated plasma volume status on all-cause and cardiovascular mortality: 4-year nationwide
Yoichiro Otaki1, Tetsu Watanabe1, Tsuneo Konta1
1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
Insights
Plasma volume status (PVS) is a significant risk factor for mortality in the general population. This study found that both high and low PVS independently predict all-cause and cardiovascular deaths, suggesting PVS is a crucial health marker.
Area of Science:
- Cardiology
- Public Health
- Biostatistics
Background:
- Plasma volume status (PVS) is increasingly recognized for its role in cardiovascular disease, particularly heart failure management.
- The association between abnormal PVS and mortality risk in the general population remains unclear.
- PVS quantifies plasma volume expansion and contraction.
Purpose of the Study:
- To investigate the association between plasma volume status (PVS) and all-cause and cardiovascular mortality.
- To determine if PVS is an independent risk factor for mortality in a large general population cohort.
Main Methods:
- Utilized a nationwide Japanese health check-up database of 230,882 adults aged 40-75 years (2008-2011).
- Followed subjects for four years, recording all-cause, cardiovascular, and non-cardiovascular deaths.
- Defined high and low PVS using specific thresholds (≥ 7 and < -13.3, respectively) and employed multivariate Cox regression analysis.
Main Results:
- High PVS was identified as an independent risk factor for all-cause, cardiovascular, and non-cardiovascular mortality.
- Low PVS was a risk factor for cardiovascular deaths but a negative risk factor for non-cardiovascular deaths.
- Incorporating PVS into existing cardiovascular risk models significantly improved predictive accuracy.
Conclusions:
- This study provides the first prospective evidence linking PVS to all-cause and cardiovascular mortality in the general population.
- Abnormal plasma volume status (both high and low) represents an additional, significant risk factor for mortality.
- PVS measurement may enhance risk stratification for cardiovascular events and overall mortality.
Background:
Plasma volume status (PVS), a marker of plasma volume expansion and contraction, is gaining attention in the field of cardiovascular disease because of its role in the prevention and of the management of heart failure. However, it remains undetermined whether an abnormal PVS is a risk for all-cause and cardiovascular mortality in the general population.
Methods And Results:
We used a nationwide database of 230,882 subjects (age 40-75 years) who participated in the annual "Specific Health Check and Guidance in Japan" check-up between 2008 and 2011. There were 586 cardiovascular deaths, 2,552 non-cardiovascular deaths, and 3,138 all-cause deaths during the follow-up period of four years. Abnormally high and low PVS were identified from the results of 80% of all subjects (high and low PVS ≥ 7 and < -13.3, respectively). Multivariate Cox proportional hazard regression analysis demonstrated that high PVS was an independent risk factor for all-cause, cardiovascular and non-cardiovascular deaths. Although low PVS was a positive risk factor for cardiovascular deaths as well, it was a negative risk factor for non-cardiovascular deaths. The addition of PVS to cardiovascular risk factors significantly improved the C-statistic, net reclassification, and integrated discrimination indexes.
Conclusions:
This is the first prospective report to reveal the impact of PVS on all-cause and cardiovascular mortality. PVS could be an additional risk factor for all-cause and cardiovascular mortality in the general population.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Related Concept Videos
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Factors affecting Blood pressure
Physiological Factors: